statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY PR...

AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY

How Is The Market Feeling About Amgen?

Amgen's Tezspire shows promising COPD trial results and potential market expansion beyond asthma. Comparison with Dupixent reveals significant benefits for eosinophil counts 150 cells/ L and 300...

Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick

AMGEN TO PRESENT TEZSPIRE PHASE 2A COPD DATA AT ATS 2024 AMGEN TO PRESENT TEZSPIRE PHASE 2A COPD DATA AT ATS 2024 PR Newswire THOUSAND OAKS, Calif., April 16, 2024 Planning Underway for Phase 3...

AMGEN TO PRESENT TEZSPIRE PHASE 2A COPD DATA AT ATS 2024

Final Trades: Shell, 2-YR T-Note and Amgen...

Final Trades: Shell, 2-YR T-Note and Amgen

Looking At Amgen's Recent Unusual Options Activity

A stock portfolio can be hedged in a number of ways, from holding bonds to taking short positions, betting that a security's price will fall.Joseph Artuso, co-manager of Easterly Snow Long/Short...

Manager of long/short mutual fund touts Amgen

The biotech industry can be attractive for several reasons. Many leading biotechs develop innovative, life-saving therapies, a business that will only be phased out once we find an all-purpose cure...

2 Biotech Stocks to Buy Hand Over Fist in April

Forza Wealth Management LLC decreased its holdings in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 2.0% in the fourth quarter, according to the company in its most recent 13F filing with the...

Forza Wealth Management LLC Sells 120 Shares of Amgen Inc. (NASDAQ:AMGN)

Stratos Wealth Partners LTD. boosted its stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 3.9% during the fourth quarter, according to the company in its most recent Form 13F filing with...

Stratos Wealth Partners LTD. Increases Holdings in Amgen Inc. (NASDAQ:AMGN)

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Volume	2.44M
52-Wk High	$329.72
52-Wk Low	$211.71

AMGN AMGEN Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals